OMV's Chemical Ambitions Face Market Skepticism Amid Restructuring

OMV's strategic pivot to chemicals via Borouge draws analyst criticism and impacts dividends, while asset sales dent production. Q1 results due April 30.

OMV's first operational report since its corporate overhaul reveals a company navigating a tricky transition. While a major asset sale has dented production figures, the Austrian energy group's future is increasingly tied to a high-stakes chemical venture that some analysts view as a growing risk.

The completion of the Borouge Group International (BGI) fusion in late March stands as the year's central strategic move. Through this alliance with XRG, the investment arm of Abu Dhabi's ADNOC, OMV now controls a global polyolefin giant with an annual capacity of 13.6 million tonnes. Management anticipates this stake will contribute approximately €140 million to group results each quarter starting in Q2. They project annual EBITDA synergies exceeding $500 million, with around 75% expected within the first three years. Further expansion is imminent, with the Borouge-4 complex slated to begin production this quarter, adding 1.4 million tonnes of capacity.

However, this chemical pivot has drawn sharp criticism from market observers. RBC Capital Markets recently downgraded OMV to "Underperform," slashing its price target to €46 from €50. The bank cut its 2026 net profit estimate by 15%, citing industry-wide overcapacity in the global chemicals sector and OMV's heightened exposure through the BGI engagement.

The company's more traditional operations presented a mixed picture in the first quarter. The January sale of its stake in Malaysian producer Sapura to TotalEnergies, which brought in close to €900 million, pushed total production down by roughly twelve percent to 310,000 barrels per day. This deal also resulted in an earnings burden of approximately €250 million for the upstream segment. In refining, plant utilization improved to 92% from 85%, but margins collapsed year-on-year, falling from €10.76 to €6.65 per barrel. The chemicals division offered a slight positive, with margins for propylene, ethylene, and polyethylene edging higher.

For income-focused shareholders, the current year involves notable compromises. In response to elevated market volatility, OMV and ADNOC postponed the planned ADX listing of BGI shares to 2027. This delay temporarily halves the BGI dividend contribution from $500 million to $250 million, translating to a reduction of about €0.60 to €0.70 per OMV share in 2026. The new payout model, which structurally decouples the dividend from the oil price and is based on 50% of BGI dividends plus 20-30% of operating cash flow, will only take full effect from 2027 onward.

Despite the analyst caution and near-term dividend headwinds, investors have so far remained supportive. The stock, trading around €61, has gained about 26% since the start of the year, comfortably above its 200-day average of €49.43. A moderate net debt ratio of 14% continues to underpin investor confidence.

All eyes are now on April 30, when OMV releases its complete first-quarter figures. This report will provide the final tally on the financial impact of the Malaysia disposal and offer clearer evidence on whether the BGI contribution can meet its ambitious targets.